Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jan 24, 2024 $44.96 $44.96 $43.49 $43.61 559 181
Jan 23, 2024 $45.38 $45.41 $43.56 $44.48 442 804
Jan 22, 2024 $44.58 $45.91 $43.72 $44.63 701 768
Jan 19, 2024 $43.36 $44.75 $42.73 $44.60 3 197 873
Jan 18, 2024 $43.64 $43.72 $41.87 $43.16 826 474
Jan 17, 2024 $43.73 $43.73 $42.76 $43.44 903 511
Jan 16, 2024 $44.92 $45.73 $43.54 $44.00 1 057 052
Jan 12, 2024 $46.40 $47.08 $45.31 $45.70 903 777
Jan 11, 2024 $46.65 $47.05 $45.74 $46.15 768 142
Jan 10, 2024 $48.45 $49.23 $46.77 $47.16 737 201
Jan 09, 2024 $49.18 $49.37 $47.70 $48.35 626 070
Jan 08, 2024 $47.59 $49.79 $46.33 $49.78 1 186 897
Jan 05, 2024 $46.51 $47.85 $45.57 $47.60 736 246
Jan 04, 2024 $48.35 $49.11 $46.75 $47.09 1 182 817
Jan 03, 2024 $47.69 $48.70 $47.08 $47.95 1 085 090
Jan 02, 2024 $47.34 $49.00 $47.34 $48.17 786 527
Dec 29, 2023 $48.25 $48.38 $47.51 $47.82 573 413
Dec 28, 2023 $49.00 $49.90 $47.72 $48.27 900 603
Dec 27, 2023 $47.75 $49.25 $47.21 $49.19 702 075
Dec 26, 2023 $48.30 $48.52 $47.50 $47.62 346 713
Dec 22, 2023 $45.63 $47.57 $45.63 $47.50 516 002
Dec 21, 2023 $45.96 $46.85 $44.80 $45.54 566 726
Dec 20, 2023 $47.94 $47.94 $45.29 $45.39 780 601
Dec 19, 2023 $45.74 $48.42 $45.64 $48.21 678 897
Dec 18, 2023 $45.94 $46.68 $44.73 $45.66 678 358
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT